You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 1, 2025

Details for Patent: 8,486,972


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,486,972 protect, and when does it expire?

Patent 8,486,972 protects SUBSYS and is included in one NDA.

This patent has twenty-three patent family members in sixteen countries.

Summary for Patent: 8,486,972
Title:Sublingual fentanyl spray
Abstract: The present invention is directed to sublingual formulations containing fentanyl, a pharmaceutically acceptable salt thereof, or derivative thereof, suitable for administration to a patient, and methods for treatment with the formulations.
Inventor(s): Kottayil; S. George (Long Grove, IL), Goskonda; Venkat R. (Gurnee, IL), Zhu; Zhongyuan (Vernon Hills, IL), Parikh; Neha (Chicago, IL), Kattookaran; Linet (Mount Prospect, IL)
Assignee: Insys Therapeutics, Inc. (Phoenix, AZ)
Application Number:11/698,739
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,486,972
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound;
Patent landscape, scope, and claims:

Detailed Analysis of the Scope and Claims of United States Patent 8,486,972

Introduction

United States Patent 8,486,972, titled "Sublingual fentanyl spray," is a patent that addresses a specific formulation and delivery method for fentanyl, a potent opioid used for pain management. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Background of the Patent

The patent, issued on July 2, 2013, is assigned to a company that has developed a unique formulation and delivery system for sublingual administration of fentanyl. This invention aims to provide an effective and convenient method for managing pain using fentanyl[4].

Scope of the Patent

Objectives of the Invention

The primary objective of the invention is to provide a fentanyl formulation suitable for sublingual administration. This involves creating a device that delivers a therapeutically effective dose of fentanyl in the form of liquid droplets with specific size distributions. The invention focuses on ensuring effective pain management through this sublingual delivery method[4].

Key Components

  • Device Description: The patent describes a device that includes a reservoir containing a unit dose of a liquid formulation of fentanyl or its derivatives. The device has an actuator that, when activated, delivers the unit dose in the form of liquid droplets.
  • Droplet Size Distribution: The droplets have a mean diameter ranging from about 10 microns to about 200 microns, with preferred ranges specified to ensure optimal delivery and absorption[4].

Claims of the Patent

Independent Claims

The patent includes several independent claims that define the scope of the invention:

  • Claim 1: This claim describes the device and its components, including the reservoir and actuator, and specifies the delivery of fentanyl in liquid droplets with a particular size distribution.
  • Claim 10: This claim focuses on the method of administering fentanyl using the described device, emphasizing the sublingual delivery and the therapeutic effectiveness of the formulation[4].

Dependent Claims

Dependent claims further detail specific aspects of the invention, such as:

  • Claim 2: This claim specifies the size distribution of the liquid droplets, providing more detailed ranges (e.g., from about 20 microns to about 100 microns).
  • Claim 3: This claim describes the pharmaceutically acceptable liquid carrier used in the formulation[4].

Patent Landscape

Related Patents and Applications

The patent landscape for sublingual fentanyl formulations is complex, with multiple patents and applications addressing similar or related technologies. For instance:

  • International Patent Offices: Similar patents may exist in other countries, accessible through databases like the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO)[1].
  • Prior Art: The Common Citation Document (CCD) application can help consolidate prior art cited by various offices, providing a comprehensive view of the existing patent landscape[1].

Competing Technologies

Other companies and inventors may have developed competing technologies for sublingual fentanyl delivery. Analyzing these through patent analytics tools, such as those provided by Schwegman, can help identify gaps and opportunities in the current patent coverage[3].

Patent Analytics and Claim Coverage

Claim Coverage Matrix

To understand the full scope of protection provided by this patent, a Claim Coverage Matrix can be used. This matrix categorizes patents and claims by scope concepts, helping to identify which claims are actively protecting the intellectual property and where gaps or opportunities exist[3].

Interactive Claim Charts

Tools like ClaimScape® software generate interactive claim charts that can be reviewed by technical experts to determine the applicability of scope concepts to target products or methods. This helps in identifying areas where claim coverage is lacking and highlights future design opportunities[3].

Legal and Regulatory Considerations

Patent Litigation

Patents like US 8,486,972 can be involved in litigation, where the validity and infringement of claims are contested. For example, inter partes review (IPR) proceedings can challenge the patentability of certain claims[5].

Expiration and Maintenance

The patent's legal status, including its expiration date and any maintenance fees, is crucial for understanding its current and future impact on the market. As of the last update, the patent was active but subject to expiration based on its filing and grant dates[4].

International Implications

Global Dossier

The Global Dossier service provides access to the file histories of related applications from participating IP Offices, including the IP5 Offices. This can help in understanding the global patent family and any international implications or challenges to the patent[1].

Machine Translations

Access to machine translations of patents from other countries, such as those provided by the EPO, JPO, and WIPO, can facilitate a more comprehensive analysis of the global patent landscape[1].

Key Takeaways

  • Specific Formulation and Delivery: The patent focuses on a specific formulation and delivery method for sublingual fentanyl administration.
  • Detailed Claims: The claims are detailed and specify the device, formulation, and delivery characteristics.
  • Patent Landscape: The patent landscape is complex, with multiple related patents and applications globally.
  • Analytics Tools: Using patent analytics tools can help in understanding the full scope of protection and identifying gaps or opportunities.
  • Legal Considerations: The patent's legal status and potential litigation are important factors to consider.

FAQs

Q: What is the primary objective of United States Patent 8,486,972?

A: The primary objective is to provide a fentanyl formulation suitable for sublingual administration for effective pain management.

Q: What are the key components of the device described in the patent?

A: The device includes a reservoir containing a unit dose of fentanyl formulation and an actuator that delivers the dose in liquid droplets with specific size distributions.

Q: How can one analyze the patent landscape for similar technologies?

A: Using tools like the Global Dossier, Common Citation Document (CCD), and patent analytics software can help in analyzing the patent landscape.

Q: What is the significance of the Claim Coverage Matrix in patent analytics?

A: The Claim Coverage Matrix helps in categorizing patents and claims by scope concepts, identifying gaps or opportunities in the current patent coverage.

Q: How can machine translations of patents from other countries be useful?

A: Machine translations provided by international patent offices can facilitate a more comprehensive analysis of the global patent landscape.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT: https://insight.rpxcorp.com/litigation_documents/12756397
  3. Patent Analytics | Intellectual Property Law: https://www.slwip.com/services/patent-analytics/
  4. US8486972B2 - Sublingual fentanyl spray - Google Patents: https://patents.google.com/patent/US8486972B2/en
  5. UNITED STATES PATENT AND TRADEMARK OFFICE ... - ExParte Inc: https://ai-lab.exparte.com/documents/ptab/ptacts-uspto/1464069/uWYAairWct6B3UmE0CNmc86OUOgJr9FLzKKOWFKba1ECTsyNsmPHn74/-13/IPR2015-01800_doc_10_exparte.pdf

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 8,486,972

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
Btcp Pharma SUBSYS fentanyl SPRAY;SUBLINGUAL 202788-001 Jan 4, 2012 DISCN Yes No ⤷  Try for Free ⤷  Try for Free Y ⤷  Try for Free
Btcp Pharma SUBSYS fentanyl SPRAY;SUBLINGUAL 202788-002 Jan 4, 2012 DISCN Yes No ⤷  Try for Free ⤷  Try for Free Y ⤷  Try for Free
Btcp Pharma SUBSYS fentanyl SPRAY;SUBLINGUAL 202788-003 Jan 4, 2012 DISCN Yes No ⤷  Try for Free ⤷  Try for Free Y ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 1 to 3 of 3 entries

International Family Members for US Patent 8,486,972

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 2007208229 ⤷  Try for Free
Brazil PI0707235 ⤷  Try for Free
Canada 2637672 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 3 of 3 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.